-
1.
公开(公告)号:US08148353B2
公开(公告)日:2012-04-03
申请号:US12462782
申请日:2009-08-06
申请人: Peter Lindsay MacDonald , Pierluigi Rossetto , Adrienne Kovacsne-Mezei , Roman Gabriel , Alexandr Jegorov , Jiri Faustmann
发明人: Peter Lindsay MacDonald , Pierluigi Rossetto , Adrienne Kovacsne-Mezei , Roman Gabriel , Alexandr Jegorov , Jiri Faustmann
CPC分类号: C07J31/006
摘要: Provided are polymorphs of fluticasone furoate and processes for preparation thereof.
摘要翻译: 提供糠酸氟替卡松的多晶型物及其制备方法。
-
2.POLYMORPHS OF SORAFENIB TOSYLATE AND SORAFENIB HEMI-TOSYLATE, AND PROCESSES FOR PREPARATION THEREOF 有权
标题翻译: 磺基苯甲酸酯和辛酰胺高聚物的多聚体及其制备方法公开(公告)号:US20090192200A1
公开(公告)日:2009-07-30
申请号:US12356004
申请日:2009-01-19
申请人: Ales Gavenda , Alexandr Jegorov , Pierluigi Rossetto , Peter Lindsay MacDonald , Augusto Canavesi
发明人: Ales Gavenda , Alexandr Jegorov , Pierluigi Rossetto , Peter Lindsay MacDonald , Augusto Canavesi
IPC分类号: A61K31/44 , C07D213/81
CPC分类号: C07D213/81
摘要: Provided are sorafenib hemi-tosylate, polymorphs thereof, polymorphs of sorafenib tosylate, preparation thereof and pharmaceutical compositions thereof.
摘要翻译: 提供索拉非尼半对甲苯磺酸酯,其多晶型物,索拉非尼甲苯磺酸盐的多晶型物,其制备方法和药物组合物。
-
3.Polymorphs of sorafenib tosylate and sorafenib hemi-tosylate, and processes for preparation thereof 有权
标题翻译: 索拉非尼甲苯磺酸盐和索拉非尼半对甲苯磺酸盐的多晶型物及其制备方法公开(公告)号:US08217061B2
公开(公告)日:2012-07-10
申请号:US12356004
申请日:2009-01-19
申请人: Ale{hacek over (s)} Gavenda , Alexandr Jegorov , Pierluigi Rossetto , Peter Lindsay MacDonald , Augusto Canavesi
发明人: Ale{hacek over (s)} Gavenda , Alexandr Jegorov , Pierluigi Rossetto , Peter Lindsay MacDonald , Augusto Canavesi
IPC分类号: A61K31/44 , C07D213/81
CPC分类号: C07D213/81
摘要: Provided are sorafenib hemi-tosylate, polymorphs thereof, polymorphs of sorafenib tosylate, preparation thereof and pharmaceutical compositions thereof.
摘要翻译: 提供索拉非尼半对甲苯磺酸酯,其多晶型物,索拉非尼甲苯磺酸盐的多晶型物,其制备方法和药物组合物。
-
4.
公开(公告)号:US20090306417A1
公开(公告)日:2009-12-10
申请号:US12583075
申请日:2009-08-12
IPC分类号: C07J1/00
CPC分类号: C07J1/00 , C07J1/007 , C07J1/0074 , C07J31/006 , C07J41/0072
摘要: Processes useful in the preparation of pharmaceutical compounds such as fulvestrant and processes for the preparation of fulvestrant.
摘要翻译: 用于制备药物化合物如氟维司群的方法和制备氟维司群的方法。
-
公开(公告)号:US20090318721A1
公开(公告)日:2009-12-24
申请号:US12583045
申请日:2009-08-12
IPC分类号: C07J1/00
CPC分类号: C07J1/00 , C07J1/007 , C07J1/0074 , C07J31/006 , C07J41/0072
摘要: Processes useful in the preparation of pharmaceutical compounds such as fulvestrant and processes for the preparation of fulvestrant.
-
公开(公告)号:US20090253913A1
公开(公告)日:2009-10-08
申请号:US12381000
申请日:2009-03-05
IPC分类号: C07D213/78 , C07D233/14
CPC分类号: C07D233/61 , C07D213/81
摘要: Methods for the synthesis of the N-carbamoyl imidazole (I) and its 1:1 adduct with imidazole are provided. Methods for the preparation of these crystalline intermediates in a high state of purity are also provided. These intermediates react cleanly under mild conditions to produce sorafenib in high yield and purity, without generating difficult-to-remove impurities.
摘要翻译: 提供了合成N-氨基甲酰基咪唑(I)及其与咪唑的1:1加合物的方法。 还提供了制备高纯度的这些结晶中间体的方法。 这些中间体在温和条件下干净地反应以高产率和纯度产生索拉非尼,而不产生难以除去的杂质。
-
公开(公告)号:US20090209754A1
公开(公告)日:2009-08-20
申请号:US12319292
申请日:2009-01-05
IPC分类号: C07H19/06
CPC分类号: C07H19/06 , C07D405/04 , C07H1/00
摘要: The present application relates to an improved process for the preparation of capecitabine.
摘要翻译: 本申请涉及用于制备卡培他滨的改进方法。
-
公开(公告)号:US20120122915A1
公开(公告)日:2012-05-17
申请号:US13336270
申请日:2011-12-23
IPC分类号: A61K31/473 , A61P1/08 , C07D471/06
CPC分类号: C07D453/02
摘要: The present invention provides crystalline forms of Palonosetron hydrochloride, processes for their preparation and pharmaceutical compositions containing such crystalline forms of Palonosetron HCl.
摘要翻译: 本发明提供盐酸帕洛诺司琼的结晶形式,其制备方法以及含有帕洛诺司琼HCl结晶形式的药物组合物。
-
公开(公告)号:US07790910B2
公开(公告)日:2010-09-07
申请号:US11192071
申请日:2005-07-27
IPC分类号: C07J1/00
CPC分类号: C07J1/00 , C07J1/007 , C07J1/0074 , C07J31/006 , C07J41/0072
摘要: Processes useful in the preparation of pharmaceutical compounds such as fulvestrant and processes for the preparation of fulvestrant.
摘要翻译: 用于制备药物化合物如氟维司群的方法和制备氟维司群的方法。
-
公开(公告)号:US07705159B2
公开(公告)日:2010-04-27
申请号:US11482228
申请日:2006-07-06
IPC分类号: C07D249/08
CPC分类号: C07D231/12 , C07D233/56 , C07D249/08
摘要: The invention provides a high-yield process for the preparation of letrozole having a high purity, without the need for removal of the 4-[1-(1,3,4-triazolyl)methyl]benzonitrile impurity at the intermediate stage. The invention also provides a process for the synthesis of letrozole in which formation of the impurity 4-[1-(1,3,4-triazolyl)methyl]benzonitrile during the first stage is minimized. In the process, a 4-(halomethyl)benzonitrile is reacted with a salt of 1H-1,2,4-triazole, reducing the formation of the impurity. Preferably, the preparation is conducted as a one-pot process.
摘要翻译: 本发明提供了用于制备具有高纯度的来曲唑的高产率方法,而不需要在中间阶段除去4- [1-(1,3,4-三唑基)甲基]苄腈杂质。 本发明还提供合成来曲唑的方法,其中第一阶段期间杂质4- [1-(1,3,4-三唑基)甲基]苄腈的形成最小化。 在此过程中,使4-(卤代甲基)苄腈与1H-1,2,4-三唑的盐反应,减少杂质的形成。 优选地,制备是作为一锅法进行的。
-
-
-
-
-
-
-
-
-